对抗剂与化学因子受体CCR2和CCR5相互作用的分子决定因素
John R D Dawson1, Grant M Wadman1, Penglie Zhang2
1Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, CA, USA.
研究人员发现了CCR2抗剂的结构原理,确定了一个新的可向槽和关键残留物,用于选择性. 这推动了基于结构的药物设计,用于炎症和免疫瘤治疗.
科学领域:
- * 药理学 药理学 药理学
- * 结构生物学 * 结构生物学
- * 计算化学 计算机化学
背景情况:
- * 化学因受体CCR2对于炎症和瘤微环境至关重要.
- *在免疫瘤学和炎症方面寻求CCR2抗剂,但面临发展挑战.
- * 基于结构的药物设计需要了解对抗作用的分子决定因素.
研究的目的:
- *阐明小分子对抗性和CCR2和CCR5.5的选择性的结构原理.
- * 确定用于CCR2和CCR5调制的新型可向接口.
- * 推进CCR2抗剂的基于结构的药物设计.
主要方法:
- * 分子对接和人工智能驱动的复合库选.
- *对和抗剂结合方式的分析.
- *功能增益突变发生用于关键残留物验证.
主要成果:
- * Orthosteric CCR2 抑制剂与非活性状态特定的道结合,揭示了一个新的潜在目标槽.
- * 聚抗体的结合受形状互补性和螺旋8相互作用的控制.
- *CCR2残留物S101^2.63和V244^6.36决定了正/全和物种选择性.
- *诱导适应在对手的识别中起着关键作用.
结论:
- *发现了关于CCR2对抗性和选择性的新型结构洞察力.
- *确定了用于CCR2和CCR5调制的新可定位接口.
- * 计算生成的模型为CCR2提供了基于结构的对手设计.
更多相关视频
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
10:03Rapid and Robust Analysis of Cellular and Molecular Polarization Induced by Chemokine Signaling
Published on: December 12, 2014
相关概念视频
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Chemotaxis and Direction of Cell Migration
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
